Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
格列酮类和α-葡萄糖苷酶抑制剂作为二线口服降糖药,与二甲双胍联合使用可降低2型糖尿病患者的心血管风险:一项全国性队列观察研究
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-018-0663-6
Chan, Cheng-Wei; Yu, Chu-Leng; Lin, Jiunn-Cherng; Hsieh, Yu-Cheng; Lin, Che-Chen; Hung, Chen-Ying; Li, Cheng-Hung; Liao, Ying-Chieh; Lo, Chu-Pin; Huang, Jin-Long; Lin, Ching-Heng; Wu, Tsu-Juey